DCUSX
Price
$14.41
Change
+$0.07 (+0.49%)
Updated
Jan 23 closing price
Net Assets
708.56M
RMEBX
Price
$57.15
Change
+$0.51 (+0.90%)
Updated
Jan 23 closing price
Net Assets
104.41B
Ad is loading...

DCUSX vs RMEBX

Header iconDCUSX vs RMEBX Comparison
Open Charts DCUSX vs RMEBXBanner chart's image
DWS CROCI US S
Price$14.41
Change+$0.07 (+0.49%)
VolumeN/A
Net Assets708.56M
American Funds American Mutual R2E
Price$57.15
Change+$0.51 (+0.90%)
VolumeN/A
Net Assets104.41B
DCUSX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DCUSX vs. RMEBX commentary
Jan 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DCUSX is a Buy and RMEBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 104B vs. DCUSX (709M). RMEBX (1.54) and DCUSX (1.47) have matching dividends . DCUSX was incepted earlier than RMEBX: DCUSX (10 years) vs RMEBX (10 years). DCUSX is a more actively managed with annual turnover of: 60.00 vs. RMEBX (25.00). RMEBX has a lower initial minimum investment than DCUSX: RMEBX (250) vs DCUSX (2500). RMEBX (13.63) and DCUSX (13.17) have marching annual gain over last year. RMEBX return over 5 years is better than : 40.60 vs. DCUSX (31.95).
DCUSXRMEBXDCUSX / RMEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years10 years-
Gain YTD3.8184.09893%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets709M104B1%
Annual Yield % from dividends1.471.5495%
Returns for 1 year13.1713.6397%
Returns for 3 years21.8016.79130%
Returns for 5 years31.9540.6079%
Returns for 10 yearsN/A64.97-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FSLR174.112.21
+1.29%
First Solar
AAMI25.660.26
+1.02%
Acadian Asset Management Inc
SHC13.690.09
+0.66%
Sotera Health Company
VERI3.15-0.03
-0.94%
Veritone
ACXP0.83-0.02
-2.36%
Acurx Pharmaceuticals